BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Finsterer J, Scorza FA. Renal manifestations of primary mitochondrial disorders. Biomed Rep 2017;6:487-94. [PMID: 28515908 DOI: 10.3892/br.2017.892] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 AbuMaziad AS, Thaker TM, Tomasiak TM, Chong CC, Galindo MK, Hoyme HE. The role of novel COQ8B mutations in glomerulopathy and related kidney defects. Am J Med Genet A 2021;185:60-7. [PMID: 33084234 DOI: 10.1002/ajmg.a.61909] [Reference Citation Analysis]
2 Finsterer J. The spectrum of renal abnormalities in mitochondrial disorders is broad. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.05.014] [Reference Citation Analysis]
3 Barone V, La Morgia C, Caporali L, Fiorini C, Carbonelli M, Gramegna LL, Bartiromo F, Tonon C, Morandi L, Liguori R, Petrini A, Brugnano R, Del Sordo R, Covarelli C, Morroni M, Lodi R, Carelli V. Case Report: Optic Atrophy and Nephropathy With m.13513G>A/MT-ND5 mtDNA Pathogenic Variant. Front Genet 2022;13:887696. [DOI: 10.3389/fgene.2022.887696] [Reference Citation Analysis]
4 Roper T, Harber M, Jones G, Pitceathly RDS, Salama AD. Delayed diagnoses of mitochondrial cytopathies in patients presenting with end stage kidney disease: two case reports. BMC Nephrol 2020;21:361. [PMID: 32838736 DOI: 10.1186/s12882-020-02002-5] [Reference Citation Analysis]
5 Finsterer J, Zarrouk-Mahjoub S. Mitochondrial cardioencephalopathy due to a COQ4 mutation. Mol Genet Metab Rep 2017;13:7-8. [PMID: 28736720 DOI: 10.1016/j.ymgmr.2017.07.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Ghanbarinejad V, Jamshidzadeh A, Khalvati B, Farshad O, Li H, Shi X, Chen Y, Ommati MM, Heidari R. Apoptosis-inducing factor plays a role in the pathogenesis of hepatic and renal injury during cholestasis. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1191-203. [PMID: 33527194 DOI: 10.1007/s00210-020-02041-7] [Reference Citation Analysis]
7 Shayota BJ, Le NT, Bekheirnia N, Rosenfeld JA, Goldstein AC, Moritz M, Bartholomew DW, Pastore MT, Xia F, Eng C, Yang Y, Lamb DJ, Scaglia F, Braun MC, Bekheirnia MR. Characterization of the renal phenotype in RMND1-related mitochondrial disease. Mol Genet Genomic Med 2019;7:e973. [PMID: 31568715 DOI: 10.1002/mgg3.973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Ge M, Fontanesi F, Merscher S, Fornoni A. The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction. Front Physiol 2020;11:732. [PMID: 32733268 DOI: 10.3389/fphys.2020.00732] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
9 Guan N, Kobayashi H, Ishii K, Davidoff O, Sha F, Ikizler TA, Hao CM, Chandel NS, Haase VH. Disruption of mitochondrial complex III in cap mesenchyme but not in ureteric progenitors results in defective nephrogenesis associated with amino acid deficiency. Kidney Int 2022:S0085-2538(22)00212-5. [PMID: 35341793 DOI: 10.1016/j.kint.2022.02.030] [Reference Citation Analysis]
10 Nugent JT, Reardon J, Crana C, Greenberg JH, Warejko JK, Goodwin JE. Fanconi syndrome, nephrotic-range proteinuria, and hypoalbuminemia in a newborn-Occam's razor or Hickam's dictum? Answers. Pediatr Nephrol 2022;37:129-32. [PMID: 34633532 DOI: 10.1007/s00467-021-05255-w] [Reference Citation Analysis]
11 Bakis H, Trimouille A, Vermorel A, Redonnet I, Goizet C, Boulestreau R, Lacombe D, Combe C, Martin-Négrier ML, Rigothier C. Adult onset tubulo-interstitial nephropathy in MT-ND5-related phenotypes. Clin Genet 2020;97:628-33. [PMID: 31713837 DOI: 10.1111/cge.13670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Wang PZT, Prasad C, Rodriguez Cuellar CI, Filler G. Nephrological and urological complications of homozygous c.974G>A (p.Arg325Gln) OSGEP mutations. Pediatr Nephrol 2018;33:2201-4. [PMID: 30141175 DOI: 10.1007/s00467-018-4060-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
13 Ommati MM, Farshad O, Mousavi K, Taghavi R, Farajvajari S, Azarpira N, Moezi L, Heidari R. Agmatine alleviates hepatic and renal injury in a rat model of obstructive jaundice. PharmaNutrition 2020;13:100212. [DOI: 10.1016/j.phanu.2020.100212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
14 Long Z, Li H, Du Y, Han B. Congenital sideroblastic anemia: Advances in gene mutations and pathophysiology. Gene 2018;668:182-9. [DOI: 10.1016/j.gene.2018.05.074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Oláhová M, Ceccatelli Berti C, Collier JJ, Alston CL, Jameson E, Jones SA, Edwards N, He L, Chinnery PF, Horvath R, Goffrini P, Taylor RW, Sayer JA. Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease. Hum Mol Genet 2019;28:3766-76. [PMID: 31435670 DOI: 10.1093/hmg/ddz202] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Jabalameli MR, Fitzpatrick FM, Colombo R, Howles SA, Leggatt G, Walker V, Wiberg A, Kunji ERS, Ennis S. Exome sequencing identifies a disease variant of the mitochondrial ATP-Mg/Pi carrier SLC25A25 in two families with kidney stones. Mol Genet Genomic Med 2021;:e1749. [PMID: 34346195 DOI: 10.1002/mgg3.1749] [Reference Citation Analysis]
17 Heidari R. The footprints of mitochondrial impairment and cellular energy crisis in the pathogenesis of xenobiotics-induced nephrotoxicity, serum electrolytes imbalance, and Fanconi's syndrome: A comprehensive review. Toxicology 2019;423:1-31. [PMID: 31095988 DOI: 10.1016/j.tox.2019.05.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
18 Gaboon NEA, Banaganapalli B, Nasser K, Razeeth M, Alsaedi MS, Rashidi OM, Abdelwehab LS, Alahmadi TS, Safdar OY, Shaik J, Choudhry HMZ, Al-Numan HH, Khan MI, Al-Aama JY, Elango R, Shaik NA. Exome sequencing and metabolomic analysis of a chronic kidney disease and hearing loss patient family revealed RMND1 mutation induced sphingolipid metabolism defects. Saudi J Biol Sci 2020;27:324-34. [PMID: 31889854 DOI: 10.1016/j.sjbs.2019.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
19 Xu S, Hu L, Yang L, Wu B, Cao Y, Zhang R, Xu X, Ma H, Zhou W, Cheng G, Zhang P, Hu L. Galloway–Mowat Syndrome Type 3 Caused by OSGEP Gene Variants: A Case Report and Literature Review. Front Pediatr 2022;10:899991. [DOI: 10.3389/fped.2022.899991] [Reference Citation Analysis]
20 Marcoux AA, Tremblay LE, Slimani S, Fiola MJ, Mac-Way F, Garneau AP, Isenring P. Molecular characteristics and physiological roles of Na+ -K+ -Cl- cotransporter 2. J Cell Physiol 2021;236:1712-29. [PMID: 32776569 DOI: 10.1002/jcp.29997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Teng H, Liang C, Liang D, Li Z, Wu L. Novel variants in OSGEP leading to Galloway-Mowat syndrome by altering its subcellular localization. Clin Chim Acta 2021;523:297-303. [PMID: 34666032 DOI: 10.1016/j.cca.2021.10.012] [Reference Citation Analysis]
22 Finsterer J. m.3243A>G carriers develop syndromic or non-syndromic multisystem phenotypes over time. CEN Case Rep 2021;10:614-5. [PMID: 33738674 DOI: 10.1007/s13730-021-00591-0] [Reference Citation Analysis]
23 Ishii K, Kobayashi H, Taguchi K, Guan N, Li A, Tong C, Davidoff O, Tran PV, Sharma M, Chandel NS, Kapp ME, Fogo AB, Brooks CR, Haase VH. Kidney epithelial targeted mitochondrial transcription factor A deficiency results in progressive mitochondrial depletion associated with severe cystic disease. Kidney Int 2021;99:657-70. [PMID: 33159962 DOI: 10.1016/j.kint.2020.10.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Yu XL, Yan CZ, Ji KQ, Lin PF, Xu XB, Dai TJ, Li W, Zhao YY. Clinical, Neuroimaging, and Pathological Analyses of 13 Chinese Leigh Syndrome Patients with Mitochondrial DNA Mutations. Chin Med J (Engl) 2018;131:2705-12. [PMID: 30425197 DOI: 10.4103/0366-6999.245265] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
25 Aldossary AM, Tawfik EA, Alomary MN, Alsudir SA, Alfahad AJ, Alshehri AA, Almughem FA, Mohammed RY, Alzaydi MM. Recent Advances in Mitochondrial Diseases: from Molecular Insights to Therapeutic Perspectives. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.05.011] [Reference Citation Analysis]
26 Koda R, Itoh R, Tsuchida M, Ohashi K, Iino N, Takada T, Narita I. Legionella Pneumonia Complicated with Acquired Fanconi Syndrome. Intern Med 2018;57:2975-80. [PMID: 29877286 DOI: 10.2169/internalmedicine.0942-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Finsterer J. Cerebral imaging in adult mitochondrial disorders. J Neurol Sci 2019;404:29-35. [PMID: 31323519 DOI: 10.1016/j.jns.2019.07.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Gödiker J, Grüneberg M, DuChesne I, Reunert J, Rust S, Westermann C, Wada Y, Classen G, Langhans CD, Schlingmann KP, Rodenburg RJ, Pohlmann R, Marquardt T. QIL1-dependent assembly of MICOS complex-lethal mutation in C19ORF70 resulting in liver disease and severe neurological retardation. J Hum Genet 2018;63:707-16. [PMID: 29618761 DOI: 10.1038/s10038-018-0442-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
29 Bernardor J, Faudeux C, Chaussenot A, Antignac C, Goldenberg A, Gubler MC, Wagner N, Bérard E. Nephrotic syndrome and mitochondrial disorders: answers. Pediatr Nephrol 2019;34:1375-7. [PMID: 30863911 DOI: 10.1007/s00467-019-04217-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
30 Forst AL, Reichold M, Kleta R, Warth R. Distinct Mitochondrial Pathologies Caused by Mutations of the Proximal Tubular Enzymes EHHADH and GATM. Front Physiol 2021;12:715485. [PMID: 34349672 DOI: 10.3389/fphys.2021.715485] [Reference Citation Analysis]
31 Schijvens AM, van de Kar NC, Bootsma-Robroeks CM, Cornelissen EA, van den Heuvel LP, Schreuder MF. Mitochondrial Disease and the Kidney With a Special Focus on CoQ10 Deficiency. Kidney Int Rep 2020;5:2146-59. [PMID: 33305107 DOI: 10.1016/j.ekir.2020.09.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
32 Tanaka K, Ueno T. Authors' reply to "m.3243A>G carriers develop syndromic or non-syndromic multisystem phenotypes over time". CEN Case Rep 2021;10:616. [PMID: 33956304 DOI: 10.1007/s13730-021-00608-8] [Reference Citation Analysis]